Michele Baer

As founder of Baer Consulting, Michele offers broad-based experience in strategic communications to her clients. For more than 15 years, she has provided marketing, patient education, PR and branding counsel to companies spanning many sectors of the healthcare industry – including OTC and Rx, biotech and medical devices, as well as Lipitor, the world’s best-selling pharmaceutical brand.

Michele has particular expertise in helping companies market their products to consumers and health professionals via the development of partnerships with advocacy groups, as well as through online marketing, special events, scientific research and the media.  She has developed a keen understanding of women’s and children’s health, neurology and cardiovascular disease.

Michele earned joint BAs from Syracuse University, an MA from the State University of New York at Stony Brook, and completed coursework at New York University’s Leonard N. Stern School of Business. She is Social Media Co-Chair and PR Chair for the Healthcare Businesswomen’s Association, and serves on the board of The SAMFund for Young Adult Survivors of Cancer.

 

Sharon Savel

Sharon brings more than 15 years of experience in patient education and advocacy development to RxEd.

Prior to joining RxEd, Sharon was co-founder and partner of The Eden Communications Group, a leading provider of patient education to the pharmaceutical industry. The business was built from the ground up and ultimately sold to Omnicom.

Sharon worked on the launch and developed patient education strategies for several blockbuster drugs, including Celebrex, Aricept, Zoloft and Neurontin. Additionally, Sharon has worked across a broad spectrum of therapeutic categories including women’s health, cardiovascular, CNS, urology and asthma and allergy. She has expertise in advocacy development and managing relationships with key nonprofit stakeholders.

She holds a BS from Northwestern University.

 

Cathy Lewis-Fink

Cathy is a leader in healthcare communications with more than 15 years of experience in patient education across a number of therapeutic categories, including depression, men’s health and cardiovascular disease.

She has expertise in advocacy development and managing relationships with key nonprofit stakeholders, as well as in developing programs for a variety of distribution channels. She worked on the launches of a number of blockbuster drugs, including Zoloft, Viagra, Lipitor and Clarinex, and created consumer education initiatives for highly targeted patient groups.

Previously, Cathy was co-founder and CEO of The Eden Communications Group, a leading provider of patient education to the pharmaceutical industry. She and Sharon Savel successfully built and sold their patient education and marketing firm to Omnicom.

Cathy holds a BA from Wesleyan University.